Laurion Capital Management’s Spyre Therapeutics SYRE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-63,026	Closed	-$3.62M	–	536
2022 Q1	$3.62M	Buy	63,026 +5,000	+9%	+$288K	0.04%	84
2021 Q4	$6.89M	Buy	58,026 +33,760	+139%	+$4.01M	0.07%	72
2021 Q3	$4.82M	Buy	+24,266	New	+$4.82M	0.02%	139